Literature DB >> 4816158

The activity of platelet factor 4 in plasma of healthy and high risk newborns.

M Alebouyeh, W Unterharnscheidt, K Riegel.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4816158     DOI: 10.1007/bf00491512

Source DB:  PubMed          Journal:  Z Kinderheilkd        ISSN: 0044-2917


× No keyword cloud information.
  16 in total

1.  INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS.

Authors:  E KOWALSKI; M KOPEC; Z WEGRZYNOWICZ
Journal:  Thromb Diath Haemorrh       Date:  1964-01-01

2.  [Direct phase-microscopic counting of thrombocytes and reticulocytes].

Authors:  S DERLATH
Journal:  Arztl Forsch       Date:  1956-11-10

3.  Isolation and properties of the third clotting factor in blood-platelets.

Authors:  S VAN CREVELD; M M PAULSSEN; R VONK
Journal:  Lancet       Date:  1952-01-05       Impact factor: 79.321

Review 4.  [Blood coagulation and its disorders in the newborn].

Authors:  W Künzer
Journal:  Klin Wochenschr       Date:  1971-01

5.  Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states.

Authors:  R Farbiszewski; S Niewiarowski; K Worowski; B Lipiński
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

6.  Hypercoagulability and thrombocytopenia after platelet factor 4infusion into rabbits.

Authors:  R Farbiszewski; B Lipiński; S Niewiarowski; A Poplawski
Journal:  Experientia       Date:  1968-06-15

7.  The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis.

Authors:  S Niewiarowski; B Lipiński; R Farbiszewski; A Poplawski
Journal:  Experientia       Date:  1968-04-15

8.  Participation of soluble fibrin monomer complexes and platelet factor 4 in the generalized Shwartzman reaction.

Authors:  B Lipiński; K Worowski; J Jeljaszewicz; S Niewiarowski; L Rejniak
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

9.  Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. I. Coagulation studies.

Authors:  M Markarian; J H Githens; E Rosenblüt; F Fernandez; J J Jackson; A E Bannon; A Lindley; L O Lubchenco; R Martorell
Journal:  Biol Neonate       Date:  1971

10.  Neutralization of antithrombin VI (fibrinogen breakdown products) with platelet antiheparin factor (platelet factor 4).

Authors:  S Niewiarowski; R Farbiszewski; A Poplawski
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15
View more
  1 in total

1.  The effect of 5-hydroxytryptamine and epinephrine on newborn platelets.

Authors:  M Alebouyeh; J M Lusher; M R Ameri; R K Evans; A Robinson
Journal:  Eur J Pediatr       Date:  1978-07-03       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.